International Flavors & Fragrances Work in process increased by 1.8% to $462.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 21.6%, from $380.00M to $462.00M. Over 5 years (FY 2020 to FY 2025), Work in process shows an upward trend with a 64.2% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $304.00M | $280.00M | $287.00M | $311.00M | $381.00M | $403.00M | $442.00M | $473.00M | $474.00M | $431.00M | $406.00M | $432.00M | $381.00M | $384.00M | $443.00M | $380.00M | $396.00M | $408.00M | $454.00M | $462.00M |
| QoQ Change | — | -7.9% | +2.5% | +8.4% | +22.5% | +5.8% | +9.7% | +7.0% | +0.2% | -9.1% | -5.8% | +6.4% | -11.8% | +0.8% | +15.4% | -14.2% | +4.2% | +3.0% | +11.3% | +1.8% |
| YoY Change | — | — | — | — | +25.3% | +43.9% | +54.0% | +52.1% | +24.4% | +6.9% | -8.1% | -8.7% | -19.6% | -10.9% | +9.1% | -12.0% | +3.9% | +6.3% | +2.5% | +21.6% |
| % of Inventories | 12.3% | 11.7% | 11.4% | 11.1% | 12.7% | 12.9% | 14.0% | 16.1% | 17.0% | 16.9% | 16.4% | 17.9% | 17.6% | 17.5% | 20.8% | 16.9% | 16.7% | 17.6% | 20.2% | 20.5% |
| Share Change | — | -0.7pp | -0.3pp | -0.3pp | +1.6pp | +0.2pp | +1.1pp | +2.0pp | +0.9pp | -0.1pp | -0.5pp | +1.5pp | -0.3pp | -0.2pp | +3.3pp | -3.9pp | -0.2pp | +0.9pp | +2.7pp | +0.3pp |